NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Li Chung Tsao
Duke University - Durham / United States
Medical and Health Sciences / General Surgery
AD Scientific Index ID: 1365852
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Li Chung Tsao's MOST POPULAR ARTICLES
1-)
Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirsL Cheng, J Ma, J Li, D Li, G Li, F Li, Q Zhang, H Yu, F Yasui, C Ye, ...The Journal of clinical investigation 127 (1), 269-279, 20171552017
2-)
NLRX1 sequesters STING to negatively regulate the interferon response, thereby facilitating the replication of HIV-1 and DNA virusesH Guo, R König, M Deng, M Riess, J Mo, L Zhang, A Petrucelli, SM Yoh, ...Cell host & microbe 19 (4), 515-528, 20161272016
3-)
Mechanisms of therapeutic antitumor monoclonal antibodiesLC Tsao, J Force, ZC HartmanCancer research 81 (18), 4641-4651, 2021972021
4-)
Vpr targets TET2 for degradation by CRL4VprBP E3 ligase to sustain IL-6 expression and enhance HIV-1 replicationL Lv, Q Wang, Y Xu, LC Tsao, T Nakagawa, H Guo, L Su, Y XiongMolecular cell 70 (5), 961-970. e5, 20181022018
5-)
CD47 blockade augmentation of trastuzumab antitumor efficacy dependent on antibody-dependent cellular phagocytosisLC Tsao, EJ Crosby, TN Trotter, P Agarwal, BJ Hwang, C Acharya, ...JCI insight 4 (24), 2019972019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept